Skip to main content

Market Overview

2 Big Medical Marijuana Stocks Riding High Post-Election

Share:
2 Big Medical Marijuana Stocks Riding High Post-Election

The surprise election of Donald Trump has gotten most of the election-related headlines following Tuesday’s vote. However, Tuesday was also a landmark day for the marijuana legalization movement. Marijuana scored medical and/or recreational victories in eight of the nine states that voted on the issue, tremendous news for the industry.

Pharma, Weed Policies And Trump

To compound the good for pharma stocks working on cannabinoid drugs, Trump’s election provided a major boost to the drug industry as well. One of the central issues of Hillary Clinton’s campaign was drug pricing, but it doesn’t seem to be a priority for Trump.

Publicly Traded Pot Stocks Go High

Marijuana drug companies GW Pharmaceuticals PLC – ADR (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) gained 6.0 percent and 3.0 percent, respectively, on Wednesday. Both stocks appeared poised to open Thursday’s session slightly higher as well. These pharma stocks traded mostly in line with non-marijuana pharma stocks like Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE), which gained 6.5 percent and 7.1 percent, respectively, on Trump's election.

While the election results were good news for marijuana drug stocks, other marijuana traders took the opportunity to cash in on huge 2016 gains. The MJIC U.S. Reporting Marijuana Index closed Wednesday’s session mostly flat but near 52-week highs.

When asked about the situation, 420 Investor Alan Brochstein told Benzinga, "Biotech rally, though there has been some speculation that the new President, with control of Congress, could be negative for state-legal cannabis."

Over-The-Counter Cannabis Stocks Sell Off

Red hot marijuana stocks such as Kush Bottles Inc (OTC: KSHB), Cannabics Pharmaceuticals Inc (OTC: CNBX) and Cannabis Sativa Inc (OTC: CBDS) weighed heavily on the index, each selling off more than 10 percent on Wednesday as traders locked in massive 2016 gains.

Image Credit: By MatthewVanitas (Own work) DC Cannabis Campaign from 2014 [CC BY-SA 3.0], via Wikimedia Commons

 

Related Articles (GWPH + ZYNE)

View Comments and Join the Discussion!

Posted-In: Analyst Color Biotech Long Ideas Health Care Politics Topics Top Stories Movers Best of Benzinga

Latest Ratings

StockFirmActionPT
PPDBairdDowngrades48.0
OSPNSidoti & Co.Upgrades39.0
PLTSidoti & Co.Upgrades48.0
LRCXArgus ResearchMaintains725.0
ROSTLoop CapitalMaintains145.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com